This compound is a modified nucleoside phosphoramidite designed for use in oligonucleotide synthesis. It features a locked nucleic acid (cEt) backbone modification and a dimethoxytrityl (DMT) protecting group, which are important for constructing chemically modified oligonucleotides used in research.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 1197033-17-2
(1R,3R,4R,7S)-3-(4-N-Benzoyl-5-methylcytosin-1-yl)-7-(2-cyanoethoxy(diisopropylamino)phosphinoxy)-1-(4,4'-dimethoxytrityloxymethyl)-2,5-dioxabicyclo(2.2.1)heptane
oligonucleotide synthesis building block
5'-ODMT cEt N-Bz A Phosphoramidite (Amidite)
DNA oligonucleotide synthesis reagent
5'-ODMT cEt m5U Phosphoramidite (Amidite)
phosphoramidite building block for oligonucleotide synthesis
(3R,4S)-4-(4-(benzyloxy)phenyl)-1-(4-fluorophenyl)-3-((S)-3-(4-fluorophenyl)-3-((trimethylsilyl)oxy)propyl)azetidin-2-one
Pharmaceutical intermediate for ezetimibe analog
3-(benzyloxy)-4-oxo-4h-pyran-2-carboxylic acid
Pharmaceutical intermediate for baloxavir marboxil
1-[2-Chloro-1-hydroxy-3-(6-quinolinyl)propyl]-2,5-pyrrolidinedione
Pharmaceutical intermediate
4-(3-Amino-1,2,4-triazin-6-yl)-2-fluorobenzonitrile
Pharmaceutical intermediate for synthesis
DMTr-LNA-C(Bz)-3-CED-phosphoramidite
oligonucleotide synthesis building block
N-[1-[(1S,3R,4R,6S,7S)-1-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-7-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-6-methyl-2,5-dioxabicyclo[2.2.1]heptan-3-yl]-5-methyl-2-oxopyrimidin-4-yl]benzamide
BDTXILPCBUAYPJ-USFFSJIASA-N
C[C@H]1[C@]2([C@H]([C@@H](O1)[C@@H](O2)N3C=C(C(=NC3=O)NC(=O)C4=CC=CC=C4)C)OP(N(C(C)C)C(C)C)OCCC#N)COC(C5=CC=CC=C5)(C6=CC=C(C=C6)OC)C7=CC=C(C=C7)OC
—